Cocrystal Pharma, Inc.
COCP
NASDAQ·Healthcare·Biotechnology·Mkt cap $15.6M
$1.13
▲ 0.00%
P/E
-1.47
Mkt Cap
$15.6M
52-Wk Range
$0.76–$2.67
52-Week Range
$0.76 - $2.67
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 24.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary structure-based drug discovery technology platform
- Strategic partnerships with Merck Sharp & Dohme Corp. and academic institutions
- Clinical validation with Phase II HCV candidate
- Focused pipeline targeting underserved viral indications
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Clinical advancement of CC-31244 HCV program toward Phase IIb trials
Value
Deep value opportunity - significant discount to Biotech & Therapeutics peers
Momentum
Strong
+11.9% over 3m
Quality
Excellent
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying COCP right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 13, 2026
AUG 13, 2026
Reported EPS of -$0.23 vs -$0.17 consensus (-39.4% surprise). Revenue of $105.0K vs $105.0K expected (0.0%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-39.4%
Revenue trend · last 8Q
—
—
—
—
—
—
—
—
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$0
$0
$0
$0
$0
$0
$225.0K
$105.0K
Margins · last 8Q
Gross
100.0%
Profit
-3013.3%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How COCP stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related